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Summary
Objective Progress through puberty involves a complex hor-
monal cascade, but the individual contributions of hormones,
particularly IGF-1, are unknown. We reanalysed Chard growth
study data to explore the tempo of puberty based on changes in
both height and hormone levels, using a novel method of
growth curve analysis.
Design and Subjects Schoolboys (n = 54) and girls (n = 70)
from Chard, Somerset, England, recruited in 1981 at age 8/9
and followed to age 16.
Measurements Every 6 months, height and Tanner stages
(genitalia, breast, pubic hair) were recorded, and in a subsample
(24 boys, 27 girls), blood samples were taken. Serum IGF-1, tes-
tosterone (boys) and oestradiol (girls) were measured by radio-
immunoassay. Individual growth curves for each outcome were
analysed using variants of the super-imposition by translation
and rotation (SITAR) method, which estimates a mean curve
and subject-specific random effects corresponding to size, and
age and magnitude of peak velocity.
Results The SITAR models fitted the data well, explaining 99%,
65%, 86% and 47% of variance for height, IGF-1, testosterone
and oestradiol, respectively, and 69–88% for the Tanner stages.
During puberty, the variables all increased steeply in value in
individuals, the ages at peak velocity for the different variables
being highly correlated, particularly for IGF-1 vs height
(r = 074 for girls, 092 for boys).
Conclusions IGF-1, like height, the sex steroids and Tanner
stages, rises steeply in individuals during puberty, with the tim-
ings of the rises tightly synchronized within individuals. This
suggests that IGF-1 may play an important role in determining
the timing of puberty.
(Received 27 October 2014; returned for revision 12 November
2014; finally revised 14 November 2014; accepted 19 November
2014)
Introduction
The period of rapid growth in height that occurs at adoles-
cence is unique to humans. No other primate species, includ-
ing the chimpanzee, has such a dramatic increase in height
velocity although the male chimpanzee does undergo a period
of rapid gain in muscle mass.1 The adolescent growth spurt
begins on average 2 years earlier in girls than boys, but within
each gender there is enormous variation in the timing of
pubertal development. It is generally accepted that the peak in
height velocity at adolescence is driven by a cascade of hor-
mones, primarily initiated by a rise in sex steroid and followed
by increases in growth hormone and the related insulin-like
growth factor 1 (IGF-1).2,3 However, deciphering the individual
contributions of these hormones, particularly IGF-1, to the
timing and intensity of pubertal growth acceleration has
proved difficult.
It has been reported that in individuals IGF-1 peaks at Tanner
stage 5,4 that raised IGF-1 is associated with early puberty5,6 and
that IGF-1 measured cross-sectionally increases both with age
and pubertal stage through puberty, peaking in girls at Tanner
stage 4.5,7 However, there is uncertainty about the longitudinal
pattern of change in IGF-1 in individuals, and how it might
relate to the timing of the rise in sex steroids (testosterone in
boys and oestradiol in girls) or the age at peak height velocity
(PHV).
The aim of this study was to use a novel method for the
analysis of growth curves which permits derivation of mean
growth curves allowing for variation in individual timing and
intensity of puberty, to examine the relationship with parallel
changes in the principal hormones IGF-1, testosterone and oes-
tradiol, and the Tanner stages. The study took advantage of the
detailed longitudinal data collected by the Chard growth study
in the 1980s.
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Methods
The Chard 2 growth study4 was a longitudinal study of 54 boys
and 70 girls recruited in 1981 from four primary schools in the
town of Chard, Somerset, England. Parents were written to when
the children were aged 8–9 years, in the penultimate year before
transfer to the secondary school. The letter explained that mea-
surements of height and weight would be taken together with
puberty ratings and a blood sample. Measurements were taken
every 6 months using appropriate equipment brought from Lon-
don and calibrated before each measuring session. The measure-
ments and puberty ratings (Tanner stages for genitalia, breast
and pubic hair)8,9 were done by two experienced auxology tech-
nicians from the growth clinic at Great Ormond Street Hospital
in London, each with a regularly assessed technical error of
height measurement close to 02 cm. The girls were seen by a
female measurer and the boys by a male. Bloods were taken
from a subsample of children (24 boys, 27 girls) whose parents
had given permission, by a medical doctor experienced at taking
blood from children. Concentrations of serum IGF-1 and testos-
terone (boys) were measured by radioimmunoassay,10,11 while
serum oestradiol (girls) was measured with the double antibody
Diagnostics Products Corp kit (Llanberis, Wales, UK). Interassay
precision was 12%, <10% and <10% for the three assays. The
study had research ethics approval from the Joint Research Eth-
ics Committee of the Institute of Child Health and Great
Ormond Street Hospital.
The longitudinal data for individuals plotted against age can
be viewed as ‘growth’ curves, which is a novel approach for the
blood-based measures and Tanner stages. The super-imposition
by translation and rotation (SITAR) method12 was used to sum-
marize these growth curves, estimating for each individual their
magnitude of peak velocity and the age when it occurred. SITAR
has previously been used to model height growth in puberty,13
and the effect on height growth of oxandrolone in Turner
Syndrome14 and calcium supplementation in Gambian
adolescents.15 It has also been used to model weight gain in
infancy.16–20
In SITAR, the individual fitted curves are assumed to be the
same underlying shape as the mean curve, but individual curves
are allowed to differ from the mean curve in three respects,
called size, tempo and velocity, which adjust the individual curves
to match the mean curve. The size parameter shifts each individ-
ual’s curve up or down, so it reflects their size relative to the
average. The tempo parameter shifts each individual’s curve left
or right and reflects their timing of puberty or age at peak
velocity. The velocity parameter stretches or shrinks the age scale
for each individual, reflecting their rate of passage through pub-
erty; this has the effect of making the growth curve steeper or
shallower and hence increasing or decreasing peak velocity. In
this way, each individual’s velocity curve is transformed to
match the mean velocity curve, at the same time estimating
individual puberty timing and intensity. The values of size,
tempo and velocity are estimated for each individual as random
effects, along with the estimate of the mean curve as a cubic
regression spline.
The term tempo was used by Tanner in two different ways,
the age at peak velocity and the rate of maturation,21 each being
effectively the inverse of the other (the earlier the age at peak
velocity, the faster the rate of maturation). Here, tempo is used
explicitly to mean the relative age at peak velocity, that is the
timing of puberty, while a separate term, velocity, is used to
describe the rate of maturation or intensity of puberty, which
manifests itself as the relative peak velocity.
The fitted models used regression splines with 3 degrees of free-
dom for the hormones and 5 degrees of freedom for height, and
the hormones were power-transformed before fitting (square root
for IGF-1 and log for testosterone and oestradiol), and back-
transformed for display. Age at peak velocity was obtained as the
age when the first derivative of the back-transformed spline curve
was maximal; its standard error was obtained with the bootstrap.
The Tanner stage data were analysed using a modified SITAR
method that fits a logistic mean curve and adjusts for tempo
(timing) and velocity (intensity), but not size.13 The size adjust-
ment is not needed as all individuals progress through the same
five stages. The slope of the logistic curve is steepest at the mid-
way point, so for Tanner stage, ‘peak velocity’ is in stage 3 and
the tempo parameter corresponds to the mean age in stage 3.13
Models were fitted using the nlme and sitar libraries in R.22,23
Results
Table 1 gives the numbers of subjects and measurements. SITAR
models were fitted to height and IGF-1 in both sexes, and to tes-
tosterone in boys and oestradiol in girls.
Fig. 1 illustrates the SITAR method applied to height. The left
panels show the individual height curves, for boys (top left) and
girls (bottom left), colour-coded with eight colours. Fitting
mean curves to the data, treating them as cross-sectional, gives
residual SDs of 74 cm in boys and 58 cm in girls. The right
panels show the same growth curves after SITAR adjustment,
and the effect of the adjustment is to superimpose the individual
curves; the residual SDs about the fitted curves are 06 cm in
boys (top right) and 05 cm in girls (bottom right), <10% of the
unadjusted residual SDs. So the variance is <1% of the unad-
justed variance, and the SITAR adjustment explains more than
99% of the variance (the values shown top left in each panel).
These residual SDs are similar to those resulting from fitting
individual Preece–Baines curves to the data,24,25 showing that
the SITAR adjustment has accounted for effectively all the
underlying interindividual growth variability.
The mean curves are shown in the right panels in black (lar-
gely obscuring the individual curves, as they are so close
together), and the mean ages at PHV are shown with vertical
dotted lines: 139 years for boys and 123 years for girls. The
corresponding mean peak velocities are 99 cm/year for boys
and 80 cm/year for girls.
Fig. 2 illustrates the SITAR analysis for IGF-1 in the two
sexes. The individual curves (left: boys top, girls bottom) are
much noisier than for height, and the underlying curve shape is
not obvious. However, the SITAR adjustment is effective at
superimposing the curves (right), and it explains two-thirds of
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the variance. The mean curves (in black) rise steeply, the most
rapid rise occurring at 132 and 120 years by sex. The curves
themselves subsequently peak and fall in both sexes, the peak
IGF-1 levels occurring at 145 years in boys and 138 years in
girls.
The correlations between the IGF-1 SITAR size and velocity
parameters in individuals are highly significant (08 in boys and
06 in girls), so subjects whose mean IGF-1 is high tend to pro-
gress more rapidly through puberty. Conversely, the correlations
between IGF-1 size and tempo are small and insignificant
(<01), indicating that the age of puberty onset is unrelated to
mean IGF-1. However tempo and IGF-1 at age 10 are signifi-
cantly negatively correlated (r = 0.4 in both sexes, p = 0.02),
so that a higher IGF-1 at this age implies earlier puberty.
Fig. 3 shows the sex steroids testosterone in boys (top) and
oestradiol in girls (bottom), in the same format as Figs 1 and 2.
The unadjusted curves are even more noisy than for IGF-1, but
despite this the SITAR adjustment explains 86% of the variance
in testosterone and 47% in oestradiol. Even after adjustment
oestradiol is very noisy past peak velocity. Both mean curves
show a steep rise, but unlike IGF-1 they continue to rise into
adulthood. Ages at peak velocity are 135 and 127 years for
testosterone and oestradiol, respectively.
The modified SITAR models used for Tanner stage also fit-
ted the data well (genitalia 69% of variance explained, breast
88%, boys pubic hair 74%, girls pubic hair 79%). The
process of adjustment is well illustrated in an earlier
publication.13
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Fig. 1 Growth curves of height in boys (above,
n = 54) and girls (below, n = 70), unadjusted (left)
and after super-imposition by translation and
rotation (SITAR) adjustment (right). The mean
curves are shown in black, and the ages at peak
height velocity are shown as dotted lines.
Table 1. Summary statistics for age at peak velocity (years) by sex
Measure
Boys Girls
Mean (SE) SD N/n* Mean (SE) SD N/n*
Height 139 (004) 097 54/510 123 (004) 103 70/733
IGF-1 132 (01) 093 24/320 120 (01) 076 27/361
Testosterone 135 (01) 104 24/321 – – –
Oestradiol – – – 127 (08) 077 27/326
Tanner genital stage 131 (02) 101 54/511 – – –
Tanner breast stage – – – 123 (02) 127 70/738
Tanner pubic hair stage 135 (03) 096 54/507 128 (04) 113 70/738
*N = no. subjects, n = no. measurements.
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Fig. 2 Growth curves of IGF-1 in boys (above,
n = 24) and girls (below, n = 27), unadjusted (left)
and after super-imposition by translation and
rotation (SITAR) adjustment (right). The mean
curves are shown in black, and the ages at peak
velocity are shown as dotted lines.
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Fig. 3 Growth curves of testosterone in boys
(above, n = 24) and oestradiol in girls (below,
n = 27), unadjusted (left) and after super-
imposition by translation and rotation (SITAR)
adjustment (right). The mean curves are shown in
black, and the ages at peak velocity are shown as
dotted lines.
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Table 1 summarizes the mean ages at peak velocity for the
measurements by sex, with their standard errors which (except
for oestradiol) are small. Peak velocity occurs consistently earlier
in girls than boys: by 16 years for height, 12 years for IGF-1
and 07–08 years for oestradiol vs testosterone and the Tanner
stages. In addition, in both sexes, peak velocity occurs earlier for
IGF-1 than for height and the sex steroids.
The standard deviations (SDs) of the individual ages at peak
velocity are also shown in Table 1; they are obtained as the SDs
of the tempo random effects for each measurement. The individ-
ual growth curves can be thought of as the mean curve shifted
left or right by an amount corresponding to the individual’s
tempo random effect, that is the difference between their own
age at peak velocity and the mean age at peak velocity; a nega-
tive tempo effect here indicates early puberty and a positive
value indicates late. These SDs, which indicate the variability of
age at puberty onset, range from 9 to 15 months in girls and 11
to 12 months in boys.
It is reasonable to expect each individual to have the same
underlying pubertal tempo according to all five measures. This
means that their tempo random effects by the different measures
ought to be correlated – they should be ranked similarly accord-
ing to all five measures. Fig. 4 (boys) and Fig. 5 (girls) examine
this by showing the correlation matrix and scatterplot matrix for
the tempo random effects based on height, IGF-1, the sex
steroids and the Tanner stages. To read off the values for a given
pair of variables, look at the rows and columns containing the
two variable names. There are two cells where the rows and
columns intersect – the one above the diagonal contains the cor-
relation and the one below contains the corresponding scatter-
plot.
The correlations are indeed nearly all large and significant and
are appreciably larger for boys than girls. The largest correla-
tions, for boys height vs IGF-1 and testosterone (r = 092 and
094, respectively, P < 00001) are remarkably high, while for
girls the oestradiol correlations with height and IGF-1 are lower
(r = 052 and 061) although still highly significant (P < 0005).
Only for oestradiol vs breast stage is the correlation <05
(although still close to significance, P = 007). The scatterplots
in Figs 4 and 5 confirm the linearity of the associations between
random effects.
Discussion
The results show the success of SITAR in modelling the com-
plexities of the adolescent growth spurt. The growth pattern for
height is well known (Fig. 1), and the SITAR model fitted to
this and similar data sets consistently explains more than 99%
of the variance.12–15 In this cohort, mean age at PHV was
123 years in girls and 139 years in boys, matching the original
report from the Chard study,4 with mean peak velocity 80 cm/
year in girls and 99 cm/year in boys, somewhat smaller than
reported originally (88 and 109)4 or by Tanner (90 and
103).26
Super-imposition by translation and rotation was also effective
in modelling the complex changes in IGF-1. It was constant
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Fig. 4 Scatterplot of tempo random effects for
height, IGF-1, testosterone and Tanner genital and
pubic hair stage in boys. The correlations (above
the diagonal) are all highly significant (P < 00001).
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during childhood but rose sharply after age 10 in girls and 11 in
boys, with peak velocity occurring 2 years later and peak level
2 years after that. A similar pattern was shown by Sorensen,5
who plotted mean IGF-1 in girls against Tanner breast stage,
where it peaked at stage 4. The age at peak velocity for IGF-1
was remarkably highly correlated with that for height. IGF-1 lev-
els at age 8 years have been shown to be predictive of age at
menarche in a recent longitudinal study,6 and the role of IGF-1
in the initiation and progression through puberty has recently
been debated.3
Testosterone and oestradiol also rose steeply in puberty, and
continued to rise afterwards. The timing of their rise was
strongly correlated with that for IGF-1 and height. SITAR
adjustment for testosterone and oestradiol explained 86% and
47% of the variance, the poorer fit for oestradiol and its lower
correlation with other markers probably reflecting variability due
to the menstrual cycle in postmenarcheal girls (whose timing
was not recorded), plus the fact that the blood samples were
taken in daytime rather than at night.27
The age at peak velocity for the Tanner stages (effectively the
age in stage 3 due to the assumed logistic model) was similarly
closely related to the timings of the other markers (see Figs 4
and 5), despite the inherent noise in the measurements.
Can we decipher the relative roles of these hormones in the
initiation and progression of the adolescent growth spurt? It is
generally accepted that the initiation of puberty relates to hypo-
thalamic pulsatile release of GnRH and in particular pituitary
secretion of predominantly LH over FSH.28 These changes lead
to gonadal maturation and critical changes in oestradiol (directly
from the ovary in girls or indirectly by aromatization of testos-
terone in boys) which prime pituitary GH release and increases
in circulating IGF-1. In rats, there is evidence that IGF-1 affects
the timing of puberty in females via its effects on LHRH29 and
KiSS-1,30 although the patterns of growth hormone secretion
and IGF-1 concentration in rats differ from those in humans,
not least because they are sexually dimorphic.
The impressive tempo-related SITAR correlations conform
with this projected sequence, although the rise in IGF-1 precedes
that for the sex steroids in individuals. This may simply reflect
the fact that in early puberty, sex steroid concentrations are
higher at night than in the day.27 The Chard subjects were sam-
pled during the day, so this would underestimate concentrations
in the girls up to breast stage 3 and the boys with testicular
volume <10 ml.
Do the data provide any insights into the relationships
between higher IGF-1 in childhood and advanced tempo? IGF-1
levels in childhood are associated with the rate of passage
through puberty, and IGF-1 at age 10 is inversely associated with
the timing of puberty. So the findings support the idea that a
higher prepubertal IGF-1 predisposes to earlier puberty.
Similarly, the reported association of the timing of puberty with
IGF-1 levels 50 years later31 squares with the findings here.
The factors that indicate GnRH pulsatility and timing of pub-
erty are still unknown, although new players such as kisspeptin
have been identified.2 The timing of pubertal onset is clearly
partly genetic32 but early developmental changes and rates of
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Fig. 5 Scatterplot of tempo random effects for
height, IGF-1, oestradiol and Tanner breast and
pubic hair stage in girls. The correlations (above
the diagonal) are all significant (P < 001) bar one.
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weight gain are also critical,33,34 which may explain associations
between IGF-1 and tempo of pubertal growth.35 Whether IGF-1
levels have a role in the initiation of pubertal development, as
has been suggested,36 remains unproven.
The data also reflect the biological discordance between the
roles of IGF-1 and sex steroids in pubertal development. The
rises in GH and IGF-1 are transient, and after reaching a peak
their concentrations decline into adulthood despite ongoing
exposure to sex steroids in concentrations known to induce
GH gene transcription. This might imply a resetting of
the hypothalamic GH regulatory peptides, GH releasing
hormone and somatostatin. In contrast oestradiol/testosterone
concentrations continue to rise into adulthood, reflecting their
role in achieving full sexual development and reproductive
capacity.
The SITAR growth curve analysis has shown its ability to
detect individual growth curves even among noisy hormone data
and has demonstrated for the first time that ages at peak velocity
for the different measures are highly correlated. With more
recent hormone assays and larger sample sizes, it should provide
further evidence as to the endocrinological patterns that underlie
pubertal onset and progression.
So in conclusion, the findings demonstrate that individuals
experience a sharp pubertal rise in IGF-1, and the age at peak
IGF-1 velocity is closely linked to the corresponding ages at peak
velocity in sex steroids, height and Tanner stages. This suggests
that IGF-1, as well as the other variables, may play an important
role in the timing of puberty.
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